Back
Global Blood Therapeutics Stock Price Chart
Buy
71
GBT
Global Blood Therapeutics
Last Price:
67.01
Seasonality Move:
-5.93%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBT is experiencing selling pressure, which indicates risk of future bearish movement.
Global Blood Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.4 | Buy |
| 20-day SMA: | 47.54 | Buy |
| 50-day SMA: | 36.73 | Buy |
| 200-day SMA: | 32.08 | Buy |
| 8-day EMA: | 62.69 | Buy |
| 20-day EMA: | 52.21 | Buy |
| 50-day EMA: | 41.58 | Buy |
| 200-day EMA: | 34.26 | Buy |
Global Blood Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.62 | Buy |
| Relative Strength Index (14 RSI): | 90.05 | Buy |
| Chaikin Money Flow: | -2492796 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (30.14 - 59.98) | Buy |
| Bollinger Bands (100): | (23.22 - 44.52) | Buy |
Global Blood Therapeutics Technical Analysis
| Aug-3 | Aug-4 | Aug-5 | Aug-8 | Aug-9 | Aug-10 | Aug-11 | Aug-12 | Aug-15 | Aug-16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Global Blood Therapeutics Stock
Is Global Blood Therapeutics Stock a Buy?
- Global Blood Therapeutics share price is 67.00 while GBT 8-day simple moving average is 66.40, which is a Buy signal.
- The stock price of GBT is 67.00 while Global Blood Therapeutics 20-day SMA is 47.54, which makes it a Buy.
- Global Blood Therapeutics 50-day simple moving average is 36.73 while GBT share price is 67.00, making it a Buy technically.
- GBT stock price is 67.00 and Global Blood Therapeutics 200-day simple moving average is 32.08, creating a Buy signal.
GBT Technical Analysis vs Fundamental Analysis
Buy
71
Global Blood Therapeutics (GBT)
is a Buy
Is Global Blood Therapeutics a Buy or a Sell?
-
Global Blood Therapeutics stock is rated a Buy
The current Global Blood Therapeutics [GBT] share price is $67.00. The Score for GBT is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Global Blood Therapeutics Stock Info
Market Cap:
4.52B
Price in USD:
67.00
Share Volume:
4.79M
Global Blood Therapeutics 52-Week Range
52-Week High:
73.02
52-Week Low:
21.65
Buy
71
Global Blood Therapeutics (GBT)
is a Buy
Global Blood Therapeutics Share Price Forecast
-
What is the Global Blood Therapeutics stock price today?
The Global Blood Therapeutics stock price is 67.00 USD today. -
Will GBT stock go up or go down?
Global Blood Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Global Blood Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Global Blood Therapeutics is not overvalued.
Is Global Blood Therapeutics Stock a Buy?
- Global Blood Therapeutics share price is 67.00 while GBT 8-day exponential moving average is 62.69, which is a Buy signal.
- The stock price of GBT is 67.00 while Global Blood Therapeutics 20-day EMA is 52.21, which makes it a Buy.
- Global Blood Therapeutics 50-day exponential moving average is 41.58 while GBT share price is 67.00, making it a Buy technically.
- GBT stock price is 67.00 and Global Blood Therapeutics 200-day simple moving average is 34.26, creating a Buy signal.
Fundamental Analysis of Global Blood Therapeutics
Is Global Blood Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.22 per share, and an increase next year of $1.81 per share.
Technical Analysis of Global Blood Therapeutics
Should I short Global Blood Therapeutics stock?
- GBT Moving Average Covergence Divergence (MACD) indicator is 9.62, suggesting Global Blood Therapeutics is a Buy
- Global Blood Therapeutics Relative Strength Index (RSI) is 90.05, which suggest Global Blood Therapeutics is overbought
- The Bollinger Bands (25) for Global Blood Therapeutics is (30.14 - 59.98), which suggest Global Blood Therapeutics is a Buy
- The Bollinger Bands (100) for Global Blood Therapeutics is (23.22 - 44.52), which suggest Global Blood Therapeutics is a Buy
* Global Blood Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.